Advertisement
Corrigendum|Articles in Press

Corrigendum to ‘Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study’ [Eur J Cancer 171 (2022) 183–192]

Published:March 10, 2023DOI:https://doi.org/10.1016/j.ejca.2022.11.027
Corrigendum to ‘Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study’ [Eur J Cancer 171 (2022) 183–192]
Previous ArticleLocal recurrence in primary localized resected gastro-intestinal stromal tumors A registry observational national cohort study including 912 patients
Next ArticleEfficacy of ipilimumab 3 mg/kg following progression on low-dose ipilimumab in metastatic melanoma
      The authors regret that the address for affiliation a was incomplete when this article was published. The correct and full address is
      a Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy
      The authors would like to apologise for any inconvenience caused.

      Article info

      Publication history

      Published online: March 10, 2023

      Publication stage

      In Press Corrected Proof

      Identification

      DOI: https://doi.org/10.1016/j.ejca.2022.11.027

      Copyright

      © 2022 Elsevier Ltd. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      Linked Article

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX